Antihypertensive mechanisms of intra-renal dopamine

Current Opinion in Nephrology and Hypertension

Volumn 24, Issue 2, 2015, Pages 117-122

  Zhang, Ming Zhi ^a   Harris, Raymond C ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

D1 like receptor; D2 like receptor; Dopamine; Hypertension; Reactive oxygen species

Indexed keywords

CYTOCHROME P450; DOPAMINE; DOPAMINE RECEPTOR; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; WATER; ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DOPAMINERGIC SYSTEM; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY INJURY; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; INJURIES; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOPAMINE; HUMANS; HYPERTENSION; KIDNEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84922627872     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000104     Document Type: Article

References (41)

1. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2:637-650.
2. Zeng C, Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension 2011; 57:11-17.
3. Quinones H, Collazo R, Moe OW. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol 2004; 287:F74-F80.
4. Pinho MJ, Serrao MP, Soares-da-Silva P. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2007; 292:F1452-F1463.
5. Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990; 258:F28-F33.
6. Bertorello A, Hokfelt T, Goldstein M, Aperia A. Proximal tubule Na+-K+- ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol 1988; 254:F795-F801.
7. Baines AD. Effects of salt intake and renal denervation on catecholamine catabolism and excretion. Kidney Int 1982; 21:316-322.
8. Bacic D, Capuano P, Baum M, et al. Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 2005; 288:F740-F747.
9. Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol 2003; 473:185-190.
10. Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 2002; 283:F221-F235.
11. Wang X, Luo Y, Escano CS, et al. Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension 2010; 55:1431-1437.
12. Zeng C, Sanada H, Watanabe H, et al. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19:233-246.
13. Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121:2845-2854.
14. Yao B, Harris RC, Zhang MZ. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension 2009; 54:1077-1083.
15. Helkamaa T, Mannisto PT, Rauhala P, et al. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens 2003; 21:2365-2374.
16. Desir GV, Peixoto AJ. Renalase in hypertension and kidney disease. Nephrol Dial Transplant 2014; 29:22-28.
17. Sizova D, Velazquez H, Sampaio-Maia B, et al. Renalase regulates renal dopamine and phosphate metabolism. Am J Physiol Renal Physiol 2013; 305:F839-F844. This study provides convincing evidence for an important role for renalase in the metabolic pathway of intrarenal dopamine.
18. Wang S, Lu X, Yang J, et al. Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 2014; 306:F588-F596.
19. Armando I, Villar VA, Jose PA. Dopamine and renal function. Compr Physiol 2011; 1:1075-1117.
20. Pasuit JB, Li Z, Kuzhikandathil EV. Multimodal regulation of endogenous D1 dopamine receptor expression and function in the CAD catecholaminergic cell line. J Neurochem 2004; 89:1508-1519.
21. Brismar H, Hua X, Adachi S, Holtback U. The role of endocytosis in renal dopamine D1 receptor signaling. Pflugers Arch 2006; 451:793-802.
22. Villar VA, Armando I, Sanada H, et al. Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension. FASEB J 2013; 27:1808-1819.
23. Villar VA, Jones JE, Armando I, et al. Sorting nexin 1 loss results in D5 dopamine receptor dysfunction in human renal proximal tubule cells and hypertension in mice. J Biol Chem 2013; 288:152-163.
24. Tobon KE, Chang D, Kuzhikandathil EV. MicroRNA 142-3p mediates posttranscriptional regulation of D1 dopamine receptor expression. PLoS One 2012; 7:e49288.
25. Granda ML, Schroeder FA, Borra RH, et al. First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring. Am J Physiol Renal Physiol 2014; 307:F116-F121.
26. Gildea JJ, Shah IT, Van Sciver RE, et al. The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport. Kidney Int 2014; 86:118-126.
27. Du Z, Yan Q, Wan L, et al. Regulation of glomerulotubular balance. I. Impact of dopamine on flow-dependent transport. Am J Physiol Renal Physiol 2012; 303:F386-F395.
28. Upadhyay VS, Muntean BS, Kathem SH, et al. Roles of dopamine receptor on chemosensory and mechanosensory primary cilia in renal epithelial cells. Front Physiol 2014; 5:72. This novel and unexpected finding may lead to new insights into the role of the intrarenal dopaminergic system.
29. Armando I, Villar VA, Jones JE, et al. Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation. FASEB J 2014; 28:1422-1434.
30. Hu MC, Di Sole F, Zhang J, et al. Chronic regulation of the renal Na(+)/H(+) exchanger NHE3 by dopamine: translational and posttranslational mechanisms. Am J Physiol Renal Physiol 2013; 304:F1169-F1180.
31. Zaika OL, Mamenko M, Palygin O, et al. Direct inhibition of basolateral Kir4.1/ 5.1 and Kir4. 1 channels in the cortical collecting duct by dopamine. Am J Physiol Renal Physiol 2013; 305:F1277-F1287. This study indicates direct targets of dopamine in the collecting duct, further confirming that dopamine can act at sites all along the nephron.
32. Zhang MZ, Wang Y, Yao B, et al. Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney. Am J Physiol Renal Physiol 2013; 305:F1680-F1686. This study provides new insights into the potential importance of cyp450 arachidonic acid metabolites as second messengers of intrarenal dopamine receptor activation
33. Fernandez MM, Gonzalez D, Williams JM, et al. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine. Eur J Pharmacol 2012; 686:97-103.
34. Lu Q, Yang Y, Villar VA, et al. D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res 2013; 36:684-690.
35. Chugh G, Lokhandwala MF, Asghar M. Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats. Am J Physiol Renal Physiol 2011; 300:F133-F138.
36. Chugh G, Lokhandwala MF, Asghar M. Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats. Hypertension 2012; 59:1029-1036.
37. Yang Y, Zhang Y, Cuevas S, et al. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med 2012; 53:437-446.
38. Yang Y, Cuevas S, Yang S, et al. Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production. Hypertension 2014; 64:825-832. This study provides important mechanistic information of the mechanisms by which dopamine can limit intrarenal production of ROS.
39. Zhang Y, Cuevas S, Asico LD, et al. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One 2012; 7:e38745.
40. Jiang X, Konkalmatt P, Yang Y, et al. Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. Hypertension 2014; 63:e74-80.
41. Zhang MZ, Yao B, Yang S, et al. Intrarenal dopamine inhibits progression of diabetic nephropathy. Diabetes 2012; 61:2575-2584.